E
Neumora Therapeutics, Inc. NMRA
$1.28 -$0.12-8.57%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses 6.21% 5.41%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -17.91% 20.09%
Operating Income 17.91% -20.09%
Income Before Tax 18.86% -23.76%
Income Tax Expenses -100.00% -57.60%
Earnings from Continuing Operations 18.92% -23.59%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 18.92% -23.59%
EBIT 17.91% -20.09%
EBITDA 17.94% -20.15%
EPS Basic 19.62% -23.13%
Normalized Basic EPS 19.55% -23.27%
EPS Diluted 19.62% -23.13%
Normalized Diluted EPS 19.55% -23.27%
Average Basic Shares Outstanding 0.88% 0.37%
Average Diluted Shares Outstanding 0.88% 0.37%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings